Jefferies Reiterates Buy Rating on Vera Therapeutics (VERA) Jun 2, 2026 03:56PM
William Blair on Vera Therapeutics (VERA): 'We believe this update has positive read-through to companies developing novel therapies for IgAN' Jun 2, 2026 02:02PM
Wolfe Research: 'VERA's continued weakness is creating a favorable setup into the July 7th PDUFA' Jun 2, 2026 12:28PM
Goldman Sachs on Vera Therapeutics (VERA): 'We are encouraged by today's update' Jun 2, 2026 11:15AM
Raymond James: ''If Vera is successful with this new plan, it could effectively shorten the theoretical lead Otsuka' Jun 2, 2026 10:12AM
View Older Stories

Jun 2, 2026 07:16AM TD Cowen on Vera Therapeutics (VERA): 'Launch prep remains on track; we have confidence in a clean approval'
May 7, 2026 07:32AM Vera Therapeutics, Inc. (VERA) Misses Q1 EPS by 36c
Mar 10, 2026 05:36PM Wolfe Research Upgrades Vera Therapeutics (VERA) to Outperform
Mar 10, 2026 10:53AM Increasing unusual call option volume: VERA HIMX SCO SAVA BNO WEAT ZVRA PROP GRPN
Mar 9, 2026 05:40PM BofA Securities Reiterates Buy Rating on Vera Therapeutics (VERA): Vertex data "appears to pose no real threat"
Jan 27, 2026 06:45AM JPMorgan on Vera Therapeutics (VERA): 'Atacicept Well Positioned Ahead Of Competitive Updates'
Jan 16, 2026 06:54AM Vera Therapeutics (VERA) Reiterated at Overweight by Cantor Fitzgerald
Dec 23, 2025 10:00AM Why Jefferies sees these stocks as standout biotech plays in 2026
Dec 19, 2025 05:13AM Vera Therapeutics (VERA) PT Raised to $66 at BofA Securities
Dec 19, 2025 03:47AM Vera Therapeutics (VERA) PT Raised to $95 at Goldman Sachs
Dec 8, 2025 04:02PM Vera Therapeutics plans $200 million stock offering
Dec 5, 2025 04:49AM Vera Therapeutics (VERA) PT Raised to $73 at TD Cowen
Dec 2, 2025 03:50PM Raymond James Reiterates Strong Buy Rating on Vera Therapeutics (VERA)
Nov 28, 2025 06:35AM H.C. Wainwright Reiterates Buy Rating on Vera Therapeutics (VERA)
Nov 26, 2025 07:05AM Vera Therapeutics' (VERA) Shares Are Still Undervalued - Cantor Fitzgerald
Nov 10, 2025 06:48AM Vera Therapeutics (VERA) PT Raised to $90 at H.C. Wainwright
Nov 5, 2025 04:16PM Vera Therapeutics, Inc. (VERA) Misses Q3 EPS by 11c
Oct 17, 2025 09:12AM Vera Therapeutics ORIGIN 3 trial to be featured at ASN Kidney Week
Oct 17, 2025 08:00AM Buy this biotech stock ahead of underdog commercial launch
Oct 16, 2025 06:40AM BofA Securities Starts Vera Therapeutics (VERA) at Buy
Oct 13, 2025 07:17AM Cantor Fitzgerald Reiterates Overweight on Vera Therapeutics (VERA); Says Shares Undervalued
Aug 5, 2025 07:48AM Vera Therapeutics, Inc. (VERA) Misses Q2 EPS by 38c
Aug 4, 2025 06:11AM Wolfe Research Downgrades Vera Therapeutics (VERA) to Peerperform
Jun 9, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on Vera Therapeutics (VERA)
Jun 6, 2025 09:45AM JPMorgan Defending Vera Therapeutics (VERA): 'pre-market weakness is overdone'
Jun 6, 2025 08:43AM Raymond James on Vera Therapeutics (VERA): 'we don’t think this is a referendum on the overall efficacy of these drugs in IgAN'
Jun 6, 2025 08:17AM Guggenheim on Vera Therapeutics (VERA): 'we would be incremental buyers on any weakness'
Jun 6, 2025 08:15AM TD Cowen Reiterates Buy Rating on Vera Therapeutics (VERA)
Jun 6, 2025 08:14AM Evercore ISI Reiterates Outperform Rating on Vera Therapeutics (VERA)
Jun 3, 2025 06:54AM Vera Therapeutics (VERA) PT Raised to $85 at H.C. Wainwright
Jun 3, 2025 05:52AM Vera Therapeutics Inc. (VERA) call put ratio 2.1 calls to 1 put with a focus on June calls and puts
Jun 3, 2025 05:43AM Increasing unusual option volume: NVTS CLBR ASTL UMAC SIG VERA FROG
Jun 2, 2025 09:58AM Increasing unusual call option volume: CLBR NVTS CERA UMAC TRVI CENX ETHA BOX ONDS RELY IBRX
Jun 2, 2025 08:52AM TD Cowen: 'We Expect Vera Therapeutics (VERA) Shares To Be Up Likely 50-75%'
Jun 2, 2025 08:25AM JPMorgan Reiterates Overweight Rating on Vera Therapeutics (VERA), Top Idea
Jun 2, 2025 07:09AM Evercore ISI Reiterates Outperform Rating on Vera Therapeutics (VERA)
Jun 2, 2025 06:31AM Vera Therapeutics Inc. (VERA) Reports Atacicept Achieved 46% Proteinuria Reduction in ORIGIN Phase 3 Trial
May 29, 2025 07:59AM Cantor Fitzgerald Reiterates Overweight Rating on Vera Therapeutics (VERA)
May 23, 2025 06:49AM Cantor Fitzgerald Reiterates Overweight Rating on Vera Therapeutics (VERA)
May 6, 2025 04:26PM Vera Therapeutics, Inc. (VERA) Misses Q1 EPS by 8c
Apr 3, 2025 08:04AM Vera Therapeutics (VERA) Completes Full Enrollment in Pivotal ORIGIN Phase 3 Trial for Atacicept in IgAN
Apr 2, 2025 07:04AM Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald
Feb 27, 2025 07:29AM Vera Therapeutics (VERA) PT Raised to $61 at Guggenheim
Feb 26, 2025 08:25AM Vera Therapeutics Inc. (VERA) Reports Q4, Provides Business Update
Feb 18, 2025 12:19PM Evercore ISI on Vera Therapeutics (VERA): 'buying opportunity'
Feb 18, 2025 06:46AM Cantor Fitzgerald Reiterates Overweight Rating on Vera Therapeutics (VERA)
Feb 14, 2025 11:12AM Vera Therapeutics Inc. (VERA) Weakness Tied to Rival Drug, Analyst Says
Nov 19, 2024 11:00AM JPM just added these stocks to its Analyst Focus List - giving one 148% upside
Oct 29, 2024 06:04AM Vera Therapeutics Inc. (VERA) Announces Proposed $300M Share Offering
Oct 7, 2024 08:22AM TD Cowen Reiterates Buy Rating on Vera Therapeutics (VERA)
View Older Stories